bioRxivPharmacology & ToxicologyPreprint
Regeneration of lung epithelial cells by Fullerene C60 nanoformulation: A possible treatment strategy for acute respiratory distress syndrome (ARDS)
Abstract
Acute respiratory distress syndrome (ARDS) involves death of lung epithelial cells. ARDS is a leading reason behind mortality in respiratory infections. Here we show a proof-of-concept that a Fullerene nanoformulation can be used for the regeneration of cells treated with apoptosis-inducing molecules, suggeting its potential for ARDS therapy.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Fatal COVID-19 and non-COVID-19 Acute Respiratory Distress Syndrome is Associated with Incomplete Alveolar Type 1 Epithelial Cell Differentiation from the Transitional State Without Fibrosis
C. Ting, M. Aspal, … R. L. Zemans·bioRxiv·Jan 12, 2021
- Proliferation of lung epithelial cells is regulated by the mechanisms of autophagy upon exposure of soots
R. Niranjan, K. P. Mishra, A. K. Thakur·bioRxiv·Sep 19, 2020
- Cell-type apoptosis in lung during SARS-CoV-2 infection
Y. Liu, T. M. Garron, … B. Gong·bioRxiv·Dec 23, 2020
- Lack of Fzd6 in Ciliated Cells Suppresses Ferroptotic Pulmonary Alveolar Cell Death Induced by LPS and Coronavirus
- Lung-Targeting Interleukin-10 mRNA Lipid Nanoparticles Ameliorate Acute Lung Injury
Yuqin Men, David O. Popoola, … Yamin Li·bioRxiv·Jan 23, 2026
- Targeting p16INK4a reverses alveolar epithelial cell dysfunction and induces lung regeneration in emphysema
Bruno Ribeiro Baptista, Marylène Toigo, … Laurent Boyer·bioRxiv·Sep 5, 2025